NPI registry status
Active
2026 NPPES data Pediatric Obesity Medicine Physician NPI 1568857415 MD
Verify on CMS → Mohamed Ali, MD
Pediatric Obesity Medicine Physician in Goshen, New York.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 24 in Pediatric Obesity Medicine Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
3K
Medicare Part D claims · 360 beneficiaries · Pediatric Obesity Medicine Physician avg: 1K
Generic prescribing
36%
generic claims · 58% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
81.4/100
▼ 2 pts below national avg 83.5 · Above neutral
Industry payments
$484.68
21 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Mohamed Ali, MD reported a CMS MIPS final score of 81.4/100 - below the 83.5 national average - and filed 3,410 Medicare Part D claims in 2024.
- 81.4/100
- MIPS score · -2 vs avg
- 3K
- Part D claims, 2024
- 36%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Mohamed Ali, MD
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1568857415), first enumerated 03/30/2015.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 3,410 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 81.4/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Industry payment transparency
$484.68 in reported industry payments (21 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- State context
State board disciplinary context
New York statewide board action statistics are published annually — these figures describe aggregate state activity, not Mohamed Ali, MD's individual license status. Verify directly with the state medical board.
Source: NYSBPMC annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1568857415 · Pediatric Obesity Medicine Physician
NPI-10 · ENUM-MID · TAX-TRACE · MIPS-INLINE · RX-MID · BOOK-THIN · NEAR-MIPS
- NPI-10 1568857415
- ENUM-MID 2015
- TAX-TRACE 24
- MIPS-INLINE 81.4/100
- RX-MID 3,410
- BOOK-THIN 4 in New York
- NEAR-MIPS Elizabeth Black, MD · 6.4
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Elizabeth Black,…
Elizabeth Black, MD
75 MIPS pts
- Ali · this provi…
Ali · this provider
81.4 MIPS pts
- Jaime Moore, M.D…
Jaime Moore, M.D.
97.6 MIPS pts
- Valerie O'Hara, …
Valerie O'Hara, DO
98.1 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Mohamed Ali, MD's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
81 ≥ 32nd percentile 32% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
✓
Board certification likely (heuristic, not verified)
Mohamed Ali, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Mohamed Ali, MD?
Near national averagePrimary specialty
Pediatric Obesity Medicine Physician
Medicare Part D claims
3,410 139% vs specialty avg
MIPS final score
81.4/100 2.1 pts vs avg
Specialty distribution in New York
How Pediatric Obesity Medicine Physician compares to other specialties among New York providers
Medicare quality performance, MIPS
Mohamed Ali, MD's 2023 MIPS final score plotted against the Pediatric Obesity Medicine Physician national average
- MIPS Final Score
- 81.4/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1568857415 |
|---|---|
| Specialty | Pediatric Obesity Medicine Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 03/30/2015 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
81.4005
Final Score
Measured-score avg: 83.5
59.6766
Quality
55.1166
Cost
100
Promoting Interoperability
Reporting: Group practice
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Mohamed Ali, MD. Source: openpaymentsdata.cms.gov.
Total received
$485
Largest payer
Lilly USA, LLC
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - New York NYSBPMC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 - they are NOT specific to Mohamed Ali, MD. To verify Mohamed Ali, MD's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases
NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Brand-heavy
Mohamed Ali, MD - brand share 58.0%
Pediatric Obesity Medicine Physician average
58% brand-name claims vs 36% generic, on 3,410 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
3,410
Total Claims
$2.2M
Total Drug Cost
360
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 7,258.8
- Total Day Supply
- 215,595
- Brand vs Generic
- 58% brand / 36% generic
- Brand Drug Cost
- $2.2M
- Generic Drug Cost
- $16K
Patient Demographics
- Average Patient Age
- 69.8 years
- Avg HCC Risk Score
- 1.72
- Gender Split
- 53% female / 47% male
- Age Distribution
- <65: 80, 65-74: 170, 75-84: 87, 85+: 23
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Mohamed Ali, MD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Ozempic
Ozempic
367 claims
- Levothyroxine Sodium
Levothyroxine Sodium
227 claims
- Jardiance
Jardiance
187 claims
- Mounjaro
Mounjaro
183 claims
- Synjardy Xr
Synjardy Xr
172 claims
- Rosuvastatin Calcium
Rosuvastatin Calcium
154 claims
- Trulicity 137
Trulicity
137 claims
- Lantus Solostar 131
Lantus Solostar
131 claims
| Drug | Claims |
|---|---|
| Ozempic Semaglutide | 367 |
| Levothyroxine Sodium | 227 |
| Jardiance Empagliflozin | 187 |
| Mounjaro Tirzepatide | 183 |
| Synjardy Xr Empagliflozin/Metformin Hcl | 172 |
| Rosuvastatin Calcium | 154 |
| Trulicity Dulaglutide | 137 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 131 |
| Metformin Hcl | 121 |
| Atorvastatin Calcium | 115 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Pediatric Obesity Medicine Physician Overview
How Mohamed Ali, MD fits within the Pediatric Obesity Medicine Physician landscape nationally.
24
Pediatric Obesity Medicine Physician Providers in US
14
States with Pediatric Obesity Medicine Physician
1,425
Avg Claims per Provider
Mohamed Ali, MD's 3,410 claims are above the specialty average of 1,425.
Nationwide Pediatric Obesity Medicine Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Ali, both outside New York so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (81.4 here).
Same NPPES enumeration year (2015)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Pediatric Obesity Medicine Physician Providers in New York
Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as Ali.
One of 4 Pediatric Obesity Medicine Physician providers enrolled in New York, 3 are shown here.
Dr. Cynthia Akagbosu
MD, MA
New York, NY
Dr. Michelle Katzow
MD
New Hyde Park, NY
Dr. Robert Rosenberg
M.D.
Hartsdale, NY
Compare Pediatric Obesity Medicine Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Mohamed Ali, MD's specialty? ▼
Mohamed Ali, MD specializes in Pediatric Obesity Medicine Physician and practices in Goshen, New York. Credentials: MD.
How much does Mohamed Ali, MD prescribe under Medicare Part D? ▼
In 2024, Mohamed Ali, MD wrote 3,410 Medicare Part D claims totaling $2.2M in drug costs for 360 beneficiaries.
What is Mohamed Ali, MD's Medicare quality score? ▼
Mohamed Ali, MD has a CMS MIPS Final Score of 81.4/100 (Quality: 59.7, Cost: 55.1). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Mohamed Ali, MD located? ▼
Mohamed Ali, MD is located at 102 CLOWES AVE, Goshen, NY, 10924. Phone: (845) 333-7200.
What is Mohamed Ali, MD's NPI number? ▼
Mohamed Ali, MD's National Provider Identifier (NPI) is 1568857415, issued on 03/30/2015.
Does Mohamed Ali, MD prescribe more brand-name or generic drugs? ▼
Mohamed Ali, MD's prescribing is 58% brand-name and 36% generic drugs by claim count, with $2.2M in brand drug costs.
How many Pediatric Obesity Medicine Physician providers are there in the US? ▼
There are 24 Pediatric Obesity Medicine Physician providers across 14 states in the US. The average Pediatric Obesity Medicine Physician provider writes 1,425 Medicare Part D claims per year.
What drugs does Mohamed Ali, MD prescribe most often? ▼
Based on 2024 Medicare Part D data, Mohamed Ali, MD's most frequently prescribed drugs include Ozempic, Levothyroxine Sodium, Jardiance. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Mohamed Ali, MD accept Medicare? ▼
Mohamed Ali, MD appears in CMS Medicare data with 3,410 Part D claims and 360 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Mohamed Ali, MD's credentials? ▼
Mohamed Ali, MD's NPI is 1568857415 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.